FDA Warns Hospira Over Injectable Drug Violations
Hospira Inc. revealed on Wednesday that it has received a U.S. Food and Drug Administration warning letter after the agency discovered "significant violations" at the company's Mulgrave, Australia, facility....To view the full article, register now.
Already a subscriber? Click here to view full article